EPIXIENNE Trademark

Trademark Overview

On Friday, August 12, 2022, a trademark application was filed for EPIXIENNE with the United States Patent and Trademark Office. The USPTO has given the EPIXIENNE trademark a serial number of 97545961. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 25, 2025. This trademark is owned by Bayer Aktiengesellschaft. The EPIXIENNE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for humans for treatment of gynecological pain diseases and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for humans for treatment of cardiological pain and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for treatment of cystic, pain, and inflammatory diseases of the kidney; pharmaceutical preparations for humans for treatment of pain and inflammation caused by hormone related disorders, cancer, or genetic deficiencies; none of the foregoing including hygiene products or preparations for treating skin disorders
epixienne

General Information

Serial Number97545961
Word MarkEPIXIENNE
Filing DateFriday, August 12, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 25, 2025

Trademark Statements

Goods and ServicesPharmaceutical preparations for humans for treatment of gynecological pain diseases and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for humans for treatment of cardiological pain and inflammatory diseases, disorders, and deficiencies; pharmaceutical preparations for treatment of cystic, pain, and inflammatory diseases of the kidney; pharmaceutical preparations for humans for treatment of pain and inflammation caused by hormone related disorders, cancer, or genetic deficiencies; none of the foregoing including hygiene products or preparations for treating skin disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBayer Aktiengesellschaft
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE
Party NameBayer Aktiengesellschaft
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLeverkusen 51373
DE

Trademark Events

Event DateEvent Description
Friday, June 2, 2023NON-FINAL ACTION WRITTEN
Tuesday, August 16, 2022NEW APPLICATION ENTERED
Wednesday, August 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 1, 2023ASSIGNED TO EXAMINER
Friday, June 2, 2023NON-FINAL ACTION E-MAILED
Friday, June 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 29, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 29, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, August 31, 2023SUSPENSION LETTER WRITTEN
Thursday, August 31, 2023LETTER OF SUSPENSION E-MAILED
Thursday, August 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 26, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, December 17, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 17, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 17, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2025ASSIGNED TO LIE
Monday, February 3, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 3, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 27, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 27, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, February 11, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 11, 2025NON-FINAL ACTION WRITTEN
Tuesday, February 11, 2025NON-FINAL ACTION E-MAILED
Friday, February 28, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 28, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, March 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 3, 2025LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 3, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

epixienne preparations diseases pharmaceutical pain disorders treatment deficiencies humans inflammatory including